Elder to tap lifestyle diseases market
The Rs 275-crore Elder Pharmaceuticals Ltd has set up 'El Life', a division dedicated to tap the about Rs 2,800 crore lifestyle diseases market. This segment has a share of about 14.7 per cent of the
The Rs 275-crore Elder Pharmaceuticals Ltd has set up 'El Life', a division dedicated to tap the about Rs 2,800 crore lifestyle diseases market. This segment has a share of about 14.7 per cent of the